Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation
CompletedOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
January 31, 2000
Primary Completion Date
December 31, 2008
Conditions
Prostate CancerOsteoporosis
Trial Locations (1)
T6G 1Z2
Cross Cancer Institute, Edmonton
All Listed Sponsors
collaborator
Cross Cancer Institute
OTHER
lead
AHS Cancer Control Alberta
OTHER
NCT00124410 - Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation | Biotech Hunter | Biotech Hunter